Wolfgang W. Scholz
Overview
Wolfgang W. Scholz received an average of $726K in total compensation, including $217K in salary, at MabVax Therapeutics Holdings from 2013 to 2015.
Source: SEC filings on May 2, 2017, May 27, 2016, and July 27, 2015.
Related executives
We found 11 more executives who work or worked at MabVax Therapeutics Holdings.
J Hansen
MabVax Therapeutics Holdings
Chief Executive Officer
Paul Resnick
MabVax Therapeutics Holdings
Vice President, Chief Business Officer
Paul Maffuid
MabVax Therapeutics Holdings
Vice President, Pharmaceutical Development and Operations
Gregory Hanson
MabVax Therapeutics Holdings
Chief Financial Officer
Michael Wick
MabVax Therapeutics Holdings
Chief Executive Officer
William Kaplan
MabVax Therapeutics Holdings
General Counsel
Wendy Wee
MabVax Therapeutics Holdings
Vice President, Finance and Controller
Steven Schow
MabVax Therapeutics Holdings